Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;40(1):75-82.
doi: 10.14366/usg.20112. Epub 2020 Sep 8.

Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force

Eun Ju Ha  1 , Jung Hwan Baek  2 , Ying Che  3 , Yi-Hong Chou  4   5   6 , Nobuhiro Fukunari  7 , Ji-Hoon Kim  8 , Wei-Che Lin  9 , Le Thi My  10 , Dong Gyu Na  11 , Lawrence Han Hwee Quek  12 , Ming-Hsun Wu  13 , Koichiro Yamakado  14 , Jianhua Zhou  15
Affiliations

Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force

Eun Ju Ha et al. Ultrasonography. 2021 Jan.

Abstract

Radiofrequency ablation (RFA) is a thermal ablation technique widely used for the management of benign thyroid nodules. To date, five academic societies in various countries have reported clinical practice guidelines, opinion statements, or recommendations regarding the use of thyroid RFA. However, despite some similarities, there are also differences among the guidelines, and a consensus is required regarding safe and effective treatment in Asian countries. Therefore, a task force was organized by the guideline committee of the Asian Conference on Tumor Ablation with the goal of devising recommendations for the clinical use of thyroid RFA. The recommendations in this article are based on a comprehensive analysis of the current literature and the consensus opinion of the task force members.

Keywords: Guidelines; Radiofrequency ablation; Thyroid; Ultrasonography.

PubMed Disclaimer

Conflict of interest statement

Dr. Baek has acted as a consultant for two companies, STARmed and RF Medical, since 2017. No other member of the guideline committee has any financial disclosure or conflict of interests to declare.

References

    1. Gharib H, Hegedus L, Pacella CM, Baek JH, Papini E. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98:3949–3957. - PubMed
    1. Kim JH, Baek JH, Lim HK, Ahn HS, Baek SM, Choi YJ, et al. 2017 Thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19:632–655. - PMC - PubMed
    1. Papini E, Pacella CM, Solbiati LA, Achille G, Barbaro D, Bernardi S, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36:376–382. - PubMed
    1. Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, et al. Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound. 2015;18:423–430. - PMC - PubMed
    1. Dobnig H, Zechmann W, Hermann M, Lehner M, Heute D, Mirzaei S, et al. Radiofrequency ablation of thyroid nodules: "Good Clinical Practice Recommendations" for Austria: an interdisciplinary statement from the following professional associations: Austrian Thyroid Association (OSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (OGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH) Wien Med Wochenschr. 2020;170:6–14. - PubMed

LinkOut - more resources